IP Library Granted Patent US 10,959,423
Granted Patent B2
US 10,959,423 · App. 15/125,871 · Granted Mar 30, 2021

Product and method for cell preservation

Inventor: Eric Faldt (Uppsala, SE)
Assignee: Cytiva Sweden AB
A01N1/021A01N1/0268B01L3/50825F25D3/08B01L2200/141B01L2300/042B01L2300/044B01L2300/0832F25D2303/0842G01N1/42
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,959,423
App. No.
15/125,871
Granted
Mar 30, 2021
Kind
B2
Abstract

The present invention relates to a product and method for cell preservation, such as cell banking of any type of cells for subsequent scientific or medical use. More closely, the invention relates to a product and a method for cryopreservation of cells using vacuum tubes provided with freeze media/cryopreservation liquid.

Claims (34)

1. A method for cryopreservation of cells from a bioreactor, the method comprising,

cultivating the cells in the bioreactor as a perfusion culture to 10-200 MVC/mL,

providing an access device having a needleless connector configured for forming a needleless connection to the bioreactor;

using the needleless connector of the access device to form a needleless connection with the bioreactor containing the cells to access the cells;

sampling or harvesting the cells from the device into a vacuum tube provided with freeze media by connecting the vacuum tube with the access device such that the cells are instantly mixed with the freeze media; and

freezing said vacuum tube for cryopreservation of the cells.

2. The method according to claim 1 , further comprising adding a freeze media into an empty vacuum tube to form the vacuum tube provided with freeze media.

3. The method according to claim 1 , wherein the freeze media is DMSO, glycerol or methyl cellulose.

4. The method according to claim 1 , wherein the vacuum tube is filled with 5-20% v/v of freeze media.

5. The method according to claim 1 , wherein one or more steps of the method are automated.

6. The method according to claim 1 , further comprising incubating the cells mixed with the freeze media in the vacuum tube before freezing.

7. The method according to claim 1 , wherein the access device comprises a needle for inserting into the vacuum tube to form the connection between the vacuum tube and the access device.

8. A method for direct cryopreservation of cultivated cells from a bioreactor, the method comprising,

cultivating the cells in the bioreactor as a perfusion culture to 10-200 MVC/mL,

providing an access device having a connector configured for forming a needleless connection to a bioreactor and a sleeved needle configured for insertion into a vacuum tube, wherein the connector and the needle are in fluid communication with each other;

using the connector of the access device to form a needleless connection with the bioreactor to access the cultivated cells;

sampling or harvesting the cells from the bioreactor by inserting a vacuum tube provided with 5-20% v/v of DMSO into the needle of the access device such that the cells are instantly mixed with the DMSO; and

freezing said vacuum tube for cryopreservation of the cells,

wherein one or more steps of the method are automated.

9. The method according to claim 8 , further comprising adding DMSO into an empty vacuum tube to form the vacuum tube provided with 5-20% v/v of DMSO.

10. The method according to claim 8 , wherein the vacuum tube is filled with about 10% v/v of DMSO.

11. The method according to claim 8 , further comprising incubating the cells mixed with DMSO in the vacuum tube before freezing.

12. The method of claim 8 , wherein the connector is a Luer, a fluid fitting used for making leak-free connections between a male-taper fitting and its mating female part.

13. A method for cryopreservation of cells from a bioreactor, the method comprising,

cultivating cells in the bioreactor as a perfusion culture to 10-200 MVC/mL,

providing an access device having a needleless connector configured for forming a needleless connection to the bioreactor;

using the needleless connector of the access device to form a needleless connection with the bioreactor to access the cultivated cells;

sampling or harvesting the cells from the bioreactor by inserting a vacuum tube provided with 5-20% v/v of freeze media into the access device such that the cells are instantly mixed with the freeze media; and

freezing said vacuum tube for cryopreservation of the cells.

14. The method according to claim 13 , further comprising adding a freeze media into an empty vacuum tube to form the vacuum tube provided with freeze media, wherein the freeze media is DMSO, glycerol or methyl cellulose.

15. The method according to claim 13 , wherein one or more steps of the method are automated.

16. The method according to claim 13 , further comprising incubating the cells mixed with freeze media in the vacuum tube before freezing.

17. The method according to claim 13 , wherein the vacuum tube is filled with about 10% v/v of DMSO.

18. The method according to claim 13 , wherein the access device comprises a needle for inserting into the vacuum tube.

Assignments (2)
CHANGE OF NAME Recorded Oct 5, 2020
From: GE HEALTHCARE BIO-SCIENCES AB
To: CYTIVA SWEDEN AB
Reel/Frame 054262/0184 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 13, 2016
From: FALDT, ERIC
To: GE HEALTHCARE BIO-SCIENCES AB
Reel/Frame 039721/0219 →
Priority Claims (1)
SE 1450373-4 · Mar 31, 2014 · national
Continuity (1)
Related Publication 20170013825A1 · Jan 19, 2017